Asia Pacific Cardiovascular Devices Market to Reach US$ 16,107.3 Mn in 2027 at CAGR of 7.0% in 2027

Asia Pacific Cardiovascular Devices Market to 2027 - Regional Analysis and Forecasts By Device (Electrocardiography (ECG), Pacemaker, Stent, Defibrillator, Cardiac Catheter, Guidewire, Heart Valve, Event Monitor, and Others); Application (Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Cerebrovascular Heart Disease and Others), End User (Hospitals, Ambulatory Surgery Centers, and Cardiac Centers), and Country

  • Report Code : TIPRE00006073
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 191
Buy Now

The Asia Pacific cardiovascular devices market is expected to reach US$ 16,107.3 Mn in 2027 from US$ 8,852.6 Mn in 2018. The market is estimated to grow with a CAGR of 7.0% from 2019-2027.

The growth of the market is driven by the factors such as, increasing acquisitions and collaboration activities and increasing rate of obesity. However, the market is likely to slower down its growth due to the shortage of skilled workers in the region.

The cardiovascular devices is an emerging field in the medical industry and has led to various developments of the products, in the field of cardiology. Many of the market players are developing novel products in order to minimize the burden of cardiovascular diseases such as heart stroke, congenital heart disease, coronary artery disease, cerebrovascular heart disease, heart arrhythmia and rheumatic heart disease. These diseases can be treated using a variety of advanced medical devices such as pacemakers, left-ventricle assist devices and implantable cardioverter defibrillators. According to the World Health Organization (WHO), particular in South Asia, 97% increase in CVD deaths experienced from 1990 to 2013. In addition, in China, nearly 230 million people out of the country’s 1.3 billion currently suffer from CVDs. In 2015, Japan-based Nipro Corp. acquired Infraredx, a U.S. company that is specialized in building intravascular imaging devices. Moreover, BSP, Ltd., an Israeli device manufacturer, which is engaged in manufacturing heart monitoring equipment, has marketing its products throughout Southeast Asia. Recently, it teamed up with Schiller, a Swiss company, to sell a variety of ECG products to hospitals and healthcare providers in Asia. The products of these companies are used in the diagnosis and monitoring of various heart conditions. Additionally, MicroPort received market approval in Indonesia to launch its Foxtrot balloon catheter, in February 2016. In January 2016, Lepu announced that it was investigating opportunities to sell its pacemakers to the Indian market. Thus, the cardiovascular devices market is anticipated to grow due to increasing acquisitions and collaboration activities in the region.

China is expected to lead the market in the Asia Pacific region owing to rising prevalence of the cardiac diseases such as heart stroke and the development for the cardiovascular devices in the country. Factors such as high prevalence of smoking, unhealthy diet has also contributed to the rising incidences of the cardiovascular diseases. Moreover, the increasing awareness and rising health plans initiated by government helps to upsurge the market growth in the country. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

ASIA PACIFIC CARDIOVASCULAR DEVICES – MARKET SEGMENTATION

By Device

  • Electrocardiography (ECG)
  • Pacemaker
  • Stent
  • Defibrillator
  • Cardiac Catheter
  • Guidewire
  • Heart Valve
  • Event Monitor
  • Others

By Application

  • Coronary Heart Disease
  • Sudden Cardiac Arrest
  • Stroke
  • Cerebrovascular Heart Disease
  • Others

By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Cardiac Centers

By Geography

  • Asia Pacific

    • China
    • Japan
    • India
    • South Korea
    • Australia

Company Profiles

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Biosense Webster, Inc. (Johnson and Johnson)
  • General Electric Company
  • Koninklijke Philips N.V
  • Siemens AG,
  • BD
  • B. Braun Melsungen AG
  • Edwards Lifesciences Corporation.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Device, Application, End User, and Country

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Australia, China, Japan, South Korea

1. Introduction

1.1 Scope Of The Study

1.2 The Insight Partners Research Report Guidance

2. Asia Pacific Cardiovascular Devices Market – Key Takeaways

3. Asia Pacific Cardiovascular Devices Market – Market Landscape

3.1 Overview

3.2 Market Segmentation

3.2.1 Asia Pacific Cardiovascular Devices Market – By Device

3.2.2 Asia Pacific Cardiovascular Devices Market – By Application

3.2.3 Asia Pacific Cardiovascular Devices Market – By End USer

3.2.4 Asia Pacific Cardiovascular Devices Market – By Country

3.3 Pest Analysis

4. Asia Pacific Cardiovascular Devices Market - Key Market Dynamics

4.1 Key Market Drivers

4.1.1 Increasing Acquisitions and Collaboration Activities

4.1.2 Increasing Rate of Obesity

4.2 Key Market Restraints

4.2.1 Shortage of Skilled Workers

4.3 Key Market Opportunities

4.3.1 Growth Opportunities in The Developing Nations

4.3.2 Declining Prices of Coronary Stents

4.4 Future Trends

4.4.1 Increasing Prevalence of Obesity Across The Region

4.5 Impact Analysis

5. Cardiovascular Devices Market – Asia Pacific Analysis

5.1 Asia Pacific Cardiovascular Devices Market Revenue Forecasts And Analysis

5.2 Market Positioning

5.2.1 Medtronic

5.2.2 Abbott

6. Asia Pacific Cardiovascular Devices Market Analysis – By Device

6.1 Overview

6.2 Asia Pacific Cardiovascular Devices Market By Device, 2018 & 2027 (%)

6.3 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (Us$ Mn)

6.4 Asia Pacific Cardiovascular Devices Volume Revenue And Forecasts To 2027, By Device (Units)

6.5 Event Monitor Market

6.5.1 Overview

6.5.2 Event Monitor Market Revenue and Forecast to 2027 (US$ Mn)

6.6 Electrocardiography (Ecg) Market

6.6.1 Overview

6.6.2 Electrocardiography (ECG) Market Revenue and Forecast to 2027 (US$ Mn)

6.7 Cardiac Catheter Market

6.7.1 Overview

6.7.2 Cardiac Catheter Market Revenue and Forecast to 2027 (US$ Mn)

6.8 Stent Market

6.8.1 Overview

6.8.2 Stent Market Revenue and Forecast to 2027 (US$ Mn)

6.9 Defibrillator Market

6.9.1 Overview

6.9.2 Defibrillator Market Revenue and Forecast to 2027 (US$ Mn)

6.10 Guidewire Market

6.10.1 Overview

6.10.2 Guidewire Market Revenue and Forecast to 2027 (US$ Mn)

6.11 Pacemaker Market

6.11.1 Overview

6.11.2 Pacemaker Market Revenue and Forecast to 2027 (US$ Mn)

6.12 Heart Valve Market

6.12.1 Overview

6.12.2 Heart Valve Market Revenue and Forecast to 2027 (US$ Mn)

6.13 Other Devices Market

6.13.1 Overview

6.13.2 Other Devices Market Revenue and Forecast to 2027 (US$ Mn)

7. Asia Pacific Cardiovascular Devices Market Analysis – By Application

7.1 Overview

7.2 Asia Pacific Cardiovascular Devices Market, By Application, 2018 & 2027 (%)

7.3 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Application (Us$ Mn)

7.4 Coronary Heart Disease Market

7.4.1 Overview

7.4.2 Coronary Heart Disease Market Revenue and Forecast to 2027 (US$ Mn)

7.5 Stroke Market

7.5.1 Overview

7.5.2 Stroke Market Revenue and Forecast to 2027 (US$ Mn)

7.6 Sudden Cardiac Arrest Market

7.6.1 Overview

7.6.2 Sudden Cardiac Arrest Market Revenue and Forecast to 2027 (US$ Mn)

7.7 Cerebrovascular Heart Disease Market

7.7.1 Overview

7.7.2 Cerebrovascular Heart Disease Market Revenue and Forecast to 2027 (US$ Mn)

7.8 Others Market

7.8.1 Overview

7.8.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

8. Asia Pacific Cardiovascular Devices Market Analysis – By End USer

8.1 Overview

8.2 Asia Pacific Cardiovascular Devices Market, By End User, 2018 & 2027 (%)

8.3 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn)

8.4 Hospitals Market

8.4.1 Overview

8.4.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)

8.5 Cardiac Centers Market

8.5.1 Overview

8.5.2 Cardiac Centres Market Revenue and Forecast to 2027 (US$ Mn)

8.6 Ambulatory Surgery Centers Market

8.6.1 Overview

8.6.2 Ambulatory Surgery Centers Market Revenue and Forecast to 2027 (US$ Mn)

9. Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027

9.1 Overview

9.2 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027 (Us$ Mn)

9.3 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (Us$ Mn)

9.4 Asia Pacific Cardiovascular Devices Volume Revenue And Forecasts To 2027, By Device (Units)

9.4.1 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.5 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn)

9.6 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Country (%)

9.7 China Cardiovascular Devices Market Revenue And Forecasts To 2027 (Us$ Mn)

9.7.1 China Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)

9.7.2 China Cardiovascular Devices Market Revenue And Forecasts to 2027, By Device (US$ Mn)

9.7.3 China Cardiovascular Devices Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.7.4 China Cardiovascular Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

9.8 Japan Cardiovascular Devices Market Revenue And Forecasts To 2027 (Us$ Mn)

9.8.1 Japan Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)

9.8.2 Japan Cardiovascular Devices Market Revenue And Forecasts to 2027, By Device (US$ Mn)

9.8.3 Japan Cardiovascular Devices Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.8.4 Japan Cardiovascular Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

9.9 India Cardiovascular Devices Market Revenue And Forecasts To 2027 (US$ Mn)

9.9.1 India Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)

9.9.2 India Cardiovascular Devices Market Revenue And Forecasts to 2027, By Device (US$ Mn)

9.9.3 India Cardiovascular Devices Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.9.4 India Cardiovascular Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

9.10 Australia Cardiovascular Devices Market Revenue And Forecasts To 2027 (Us$ Mn)

9.10.1 Australia Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)

9.10.2 Australia Cardiovascular Devices Market Revenue And Forecasts to 2027, By Device (US$ Mn)

9.10.3 Australia Cardiovascular Devices Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.10.4 Australia Cardiovascular Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.11 South Korea Cardiovascular Devices Market Revenue And Forecasts To 2027 (US$ Mn)

9.11.1 South Korea Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)

9.11.2 South Korea Cardiovascular Devices Market Revenue And Forecasts to 2027, By Device (US$ Mn)

9.11.3 South Korea Cardiovascular Devices Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.11.4 South Korea Cardiovascular Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

10. Cardiovascular Devices Market – Industry Landscape

10.1 Overview

10.2 Growth Strategies Done By The Companies In The Market, (%)

10.3 Organic Growth Strategies

10.3.1 Overview

10.3.2 Product Launch & Up Gradation

10.3.3 Approvals

10.3.4 Others Developments

10.4 Inorganic Growth Strategies

10.4.1 Overview

10.4.2 Acquisition

10.4.3 Collaboration & Agreement

11. Cardiovascular devices Market – Key Company Profiles

11.1 Medtronic

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Financial Overview

11.1.4 Product Portfolio

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Boston Scientific Corporation

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Financial Overview

11.2.4 Product Portfolio

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Abbott

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Financial Information

11.3.4 Product Portfolio

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Biosense Webster, Inc (Johnson And Johnson)

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Financial Information

11.4.4 Product Portfolio

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 General Electric Company

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Financial Overview

11.5.4 Product Portfolio

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Koninklijke Philips N.V.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Financial Overview

11.6.4 Product Portfolio

11.6.5 SWOT ANALYSIS

11.6.6 Key Developments

11.7 Siemens Ag

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Financial Overview

11.7.4 Product Portfolio

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 BD

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Financial Overview

11.8.4 Product Portfolio

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 B. Braun Melsungen Ag

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Financial Overview

11.9.4 Product Portfolio

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Edwards Lifesciences Corporation

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Overview

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary Of Terms

12.3 Methodology

12.3.1 Coverage

12.3.2 Secondary Research

12.3.3 Primary Research


LIST OF TABLES

Table 1. Obese Population Across The Region, 2017

Table 2. Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (US$ Mn)

Table 3. Asia Pacific Cardiovascular Devices Market Volume And Forecasts To 2027, By Device (Units)

Table 4. Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 5. Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 6. Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (US$ Mn)

Table 7. Asia Pacific Cardiovascular Devices Market Volume And Forecasts To 2027, By Device (Units)

Table 8. Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 9. Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 10. China Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (US$ Mn)

Table 11. China Cardiovascular Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 12. China Cardiovascular Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 13. Japan Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (US$ Mn)

Table 14. Japan Cardiovascular Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 15. Japan Cardiovascular Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 16. India Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (US$ Mn)

Table 17. India Cardiovascular Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 18. India Cardiovascular Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 19. Australia Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (US$ Mn)

Table 20. Australia Cardiovascular Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 21. Australia Cardiovascular Devices Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 22. South Korea Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (US$ Mn)

Table 23. South Korea Cardiovascular Devices Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 24. South Korea Cardiovascular Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 25. Recent Product Launch & Upgradation In The Cardiovascular Devices Market

Table 26. Recent Approvals In The Cardiovascular Devices Market

Table 27. Recent Others Developments In The Cardiovascular Devices Market

Table 28. Acquisitions In The Cardiovascular Devices Market

Table 29. Collaboration In The Cardiovascular Devices Market

Table 30. Glossary Of Terms, Cardiovascular Devices Market

LIST OF FIGURES

Figure 1. China Cardiovascular Devices Market, Revenue (US$ Mn), By Country 2018 & 2027

Figure 2. Asia Pacific Cardiovascular Devices Market By Device, Market Share (%), 2018

Figure 3. Asia Pacific Cardiovascular Devices Market By Application, Market Share (%), 2018

Figure 4. Asia Pacific Cardiovascular Devices Market By End USer, Market Share (%), 2018

Figure 5. Cardiovascular Devices Market Segmentation

Figure 6. Asia Pacific Pest Analysis

Figure 7. Cardiovascular Devices Market Impact Analysis Of Drivers & Restraints

Figure 8. Asia Pacific Cardiovascular Devices Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 9. Market Positioning Of Key Player In Asia Pacific Cardiovascular Devices Market

Figure 10. Asia Pacific Cardiovascular Devices Market, By Device 2018 & 2027 (%)

Figure 11. Event Monitor Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12. Electrocardiography (Ecg) Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13. Cardiac Catheter Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14. Stent Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 15. Defibrillator Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16. Guidewire Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17. Pacemaker Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 18. Heart Valve Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19. Other Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20. Asia Pacific Cardiovascular Devices Market By Application, 2018 & 2027 (%)

Figure 21. Coronary Heart Disease Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22. Stroke Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 23. Sudden Cardiac Arrest Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24. Cerebrovascular Heart Disease Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25. Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26. Asia Pacific Cardiovascular Devices Market By End User, 2018 & 2027 (%)

Figure 27. Hospitals Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 28. Cardiac Centres Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 29. Ambulatory Surgery Centers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 30. Asia Pacific Cardiovascular Devices Market Revenue Overview, By Country, 2018 (US$ Mn)

Figure 31. Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 32. Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Country (%)

Figure 33. China Cardiovascular Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 34. Japan Cardiovascular Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 35. India Cardiovascular Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 36. Australia Cardiovascular Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 37. South Korea Cardiovascular Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 38. Growth Strategies Done By The Companies In The Market, (%)

Figure 39. Organic Growth Strategies In The Cardiovascular Devices Market, 2016-2019

Figure 40. Inorganic Growth Strategies In The Cardiovascular Devices Market, 2016-2019

The List of Companies

  1. Medtronic
  2. Boston Scientific Corporation
  3. Abbott
  4. Biosense Webster, Inc. (Johnson and Johnson)
  5. General Electric Company
  6. Koninklijke Philips N.V
  7. Siemens AG,
  8. BD
  9. B. Braun Melsungen AG
  10. Edwards Lifesciences Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Asia Pacific Cardiovascular Devices Market